Why Teva Pharmaceutical Stock Is Sliding Today
Shares of Teva Pharmaceutical Industries (NYSE: TEVA) were sliding 5.4% lower as of 11:47 a.m. ET on Wednesday. The decline came after the drugmaker announced its 2022 full-year and fourth-quarter results. Teva reported fourth-quarter revenue of $3.88 billion, down 5% year over year.